This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Years of investment in digital, cloud and security strategy has helped Accenture evolve as a trusted and viable consulting services provider. It is currently the world’s top consultancy firm by revenues that increased 5% in 2019 with a contribution of 56% from consulting services.
Accenture (ACN) and BBVA Sign 10-Year Collaborative Agreement
by Zacks Equity Research
Accenture (ACN) lets BBVA use its AI powered SynOps platform for data-driven decision-making, improved operational costs and streamlined services.
FactSet's (FDS) Earnings and Revenues Beat Estimates in Q1
by Zacks Equity Research
FactSet's (FDS) first-quarter fiscal 2022 earnings and revenues increase year over year.
Is Accenture (ACN) Outperforming Other Business Services Stocks This Year?
by Zacks Equity Research
Here is how Accenture (ACN) and Marvell Technology (MRVL) have performed compared to their sector so far this year.
Paychex (PAYX) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Paychex (PAYX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
5 Momentum Stocks for Keeping Your Portfolio Warm This Winter
by Aniruddha Ganguly
Here we pick five momentum stocks ¿¿¿ Photronics (PLAB), Preferred Apartment (APTS), Accenture (ACN), Broadcom (AVGO) and Jabil (JBL) ¿¿¿ which can keep your returns hot this chilly winter.
Paychex (PAYX) Set to Report Q2 Earnings: What to Expect?
by Zacks Equity Research
Paychex's (PAYX) second-quarter fiscal 2022 earnings and revenues are likely to have increased year over year.
Company News for Dec 17, 2021
by Zacks Equity Research
Companies in the news are: ACN, JBL, SNAX, ML
Accenture (ACN) Q1 Earnings, Revenues Top Estimates, View Up
by Zacks Equity Research
Accenture's (ACN) first-quarter fiscal 2022 earnings benefit from higher revenues and lower share count.
IBM Watson Health Helps Enterprises Implement COVID-19 Testing
by Zacks Equity Research
International Business Machines (IBM) Digital Health integrates IBM Digital Health Pass to verify COVID-19 testing and vaccination requirements.
Accenture (ACN) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Accenture (ACN) delivered earnings and revenue surprises of 6.11% and 5.40%, respectively, for the quarter ended November 2021. Do the numbers hold clues to what lies ahead for the stock?
What's in the Cards for Accenture (ACN) in Q1 Earnings?
by Zacks Equity Research
Accenture's (ACN) first-quarter fiscal 2022 earnings and revenues are expected to have improved year over year.
Accenture (ACN) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Accenture (ACN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Accenture (ACN) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Accenture (ACN) closed at $374.53, marking a +0.86% move from the previous day.
III or ACN: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
III vs. ACN: Which Stock Is the Better Value Option?
Splunk (SPLK) Tops Estimates in Q3 Earnings, Revenues Up Y/Y
by Zacks Equity Research
Splunk's (SPLK) third-quarter fiscal 2022 results reflect growth in cloud revenues and customer base expansion amid higher expenses.
The Zacks Analyst Blog Highlights: Accenture, Raytheon, Becton, Dickinson and Co, Boeing and Gilead Sciences
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Accenture, Raytheon, Becton, Dickinson and Co, Boeing and Gilead Sciences
Top Analyst Reports for Accenture, Raytheon & Becton, Dickinson
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Accenture plc (ACN), Raytheon Technologies Corporation (RTX), and Becton, Dickinson, and Company (BDX).
Splunk (SPLK) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Splunk's (SPLK) second-quarter fiscal 2022 performance will likely reflect software revenue growth and customer wins. High demand for cloud-based solutions is expected to drive subscription revenues.
Accenture (ACN) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Accenture (ACN) closed at $360.70, marking a -0.72% move from the previous day.
III vs. ACN: Which Stock Is the Better Value Option?
by Zacks Equity Research
III vs. ACN: Which Stock Is the Better Value Option?
Infosys (INFY) Upgrades South Florida Water Management to HANA
by Zacks Equity Research
Infosys (INFY) aids South Florida Water Management District with the SAP S/4HANA platform to improve its service efficiencies, and boost employee productivity.
Accenture (ACN) to Gain From Tambourine Buyout: Here's How
by Zacks Equity Research
The latest deal is expected to strengthen the commerce transformation capabilities of Accenture (ACN) in the Japanese market.
Here's Why Investors Should Retain Accenture (ACN) Stock Now
by Zacks Equity Research
Strategic acquisitions and strong cash balance are boosting Accenture (ACN). Higher talent cost is a concern.
Accenture (ACN) to Benefit From T.A. Cook Buyout: Here's How
by Zacks Equity Research
The latest deal is expected to strengthen the asset performance management capabilities of Accenture's (ACN) Industry X group.
Accenture (ACN) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Accenture (ACN) closed the most recent trading day at $366.93, moving -0.42% from the previous trading session.